Christoph E. Heilig

Also affiliated with Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Deutsches Konsortium für Translationale Krebsforschung

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies”.

487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies

Annals of Oncology(2022)10.1016/j.annonc.2022.07.615

N/A

0DataRank · unranked

3 citations

M-V. Teleanu, Irfan A. Bhatti, Susan Richter, Jens T. Siveke, Stephan N. Wagner +14 more